Clinical Trial Update: Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN [Phase 4]

View source ↗

Summary

Phase 4 study evaluating ocular surface effects of Travatan Z (travoprost) and XALATAN (latanoprost) in open-angle glaucoma and ocular hypertension; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TRAVATAN Z (TRAVOPROST)
• Xalatan (latanoprost)

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-04-23